Business
TerrAscend Preannounces Strong Second Quarter Results
TerrAscend Preannounces Strong Second Quarter Results Canada NewsWire NEW YORK a...
About this update from Terrascend Corp.
[{"type":"text","content":"\n\n\n\nTerrAscend Preannounces Strong Second Quarter Results\n\n/* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n.prngen2{\nBORDER-TOP:1pt; BORDER-RIGHT:1pt; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM:1pt; PADDING-LEFT:0.50em; BORDER-LEFT:1pt; PADDING-RIGHT:0.50em\n}\n.prntac{\nTEXT-ALIGN: CENTER\n}\n.prnsbb1{\nBORDER-BOTTOM:1pt\n}\n.prnsbr1{\nBORDER-RIGHT:1pt\n}\n.prnpr6{\nPADDING-RIGHT:0.50em\n}\n.prnpl6{\nPADDING-LEFT:0.50em\n}\n.prnsbt1{\nBORDER-TOP:1pt\n}\n.prnvat{\nVERTICAL-ALIGN: TOP\n}\n.prntblns{\nBORDER-TOP: 1pt; BORDER-RIGHT: 1pt; BORDER-COLLAPSE: collapse; BORDER-BOTTOM: 1pt; BORDER-LEFT: 1pt\n}\n.prnsbl1{\nBORDER-LEFT:1pt\n}\n\n\n\n\n\n\n\nCanada NewsWire\nNEW YORK and TORONTO, Aug. 6, 2020\n\n\n\n -  NET SALES OF $47.2 MILLION AND ADJUSTED EBITDA OF $11.4 MILLION\n-  Net Sales increased 36% quarter-over-quarter and 169% year-over-year\n-  Adjusted EBITDA increased to $11.4 Million, a 131% improvement quarter-over-quarter\n-  Adjusted EBITDA Margin expands sequentially to 24% from 14%\n-  Adjusted Gross Margin expands sequentially to 56% from 45%\n NEW YORK and TORONTO, Aug. 6, 2020 /CNW/ - TerrAscend Corp. (CSE: TER) (OTCQX: TRSSF) (\"TerrAscend\" or the \"Company\") a leading North American cannabis operator, today announced preliminary financial results for its second quarter ending June 30, 2020. All amounts are in Canadian dollars. Based on a preliminary (unaudited) review, the Company anticipates:\nNet Sales increased 36% sequentially and 169% year over year to $47.2 million US operations generated 90% of consolidated Net Sales Adjusted EBITDA of $11.4 million, increasing 131% sequentially Adjusted Gross Margin of 56% (before gain on fair value of biological assets) Cash and Cash equivalents of $75 million as of June 30th, 2020\"Our strong top and bottom-line performance reflects our unwavering commitment to achieve best-in-class results from our operations,\" said Jason Ackerman, CEO and Executive Chairman of TerrAscend. \"We have been thoughtful in our approach to expanding our business, primarily focused on the areas of the U.S. marke...